This Viewpoint explores the US Supreme Court’s ruling in Loper Bright Enterprises v Raimondo and the implications the ruling could have on the regulation of laboratory-developed tests and public health.
No takes yet. Share an insight, caveat, or question.
Simón et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: